Close Lucintel Chat
Didn't Find What You're Looking for?
Call us at +1972 636 5056 or write at helpdesk@Lucintel.com
Ask an Expert Provide Custom Requirements Download Sample Report Search Available Reports
  • helpdesk@Lucintel.com
  • |
  • Call Lucintel +1 972 636 5056
  • |
  • Login
  • |
  • Register
  • |
  • Search
  • |
'
...

The Impact of COVID-19 is included in Cancer Biomarker Market. Buy it today to get an advantage.

Request the impact of COVID-19 on your product or industry


The future of the cancer biomarker market looks promising with opportunities in the diagnostics, research, prognostics, and risk assessment. The global cancer biomarkers market is expected to grow wi

th a CAGR of 12% from 2019 to 2024. The major growth drivers for this market are technological advancements, rising incidence of cancer, and increasing use of cancer biomarkers in drug discovery and development, and increasing research on cancer biomarkers.

A report of more than 150 pages is developed to help in your business decisions. Sample figures with some insights are shown below. To learn the scope of, benefits, companies researched and other details of cancer biomarker market report download the report brochure.



Cancer Biomarker Market by Segments

Cancer Biomarker Market Trends and Forecast

Cancer Biomarker Market Share
 


The study includes the cancer biomarker market size and forecast for the global cancer biomarker market through 2024, segmented by profiling technology, biomolecules type, cancer type, method, application, and region as follows:

By Profiling Technology [$M shipment analysis for 2013 – 2024]:
  • Omics
  • Imaging Technologies
  • Immunoassays
  • Cytogenetics
  • Bioinformatics

By Biomolecules Type [$M shipment analysis for 2013 – 2024]:
  • Protein Biomarkers
  • Genetic Biomarkers
  • Other Cancer Biomarkers

By Cancer Type [$M shipment analysis for 2013 – 2024]:
  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • Thyroid Cancer
  • Kidney Cancer
  • Other Cancers

By Method [$M shipment analysis for 2013 – 2024]:
  • Sample Preparation
  • Assay Development
  • Biomarkers and Testing

By Application [$M shipment analysis for 2013 – 2024]:
  • Diagnostics
  • Research
  • Prognostics
  • Risk Assessment
  • Others

By Region [$M shipment analysis for 2013 – 2024]:
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
  • Rest of the World
    • Brazil

Some of the cancer biomarker companies profiled in this report include Thermo Fisher Scientific, Roche Diagnostics, Qiagen N.V., Illumina, Agilent Technologies, Biomérieux, Merck & Co., Abbott Laboratories, Becton Dickinson, and Quest Diagnostics.

Some of the features of this report:
  • Market size estimates: Global cancer biomarker market size estimation in terms of value ($M) shipment.
  • Trend and forecast analysis: Market trend (2013-2018) and forecast (2019-2024) by segments and region.
  • Segmentation analysis: Global market size by profiling technology, biomolecules type, cancer type, method, application, and region.
  • Regional analysis: Global cancer biomarker market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
  • Growth opportunities: Analysis on growth opportunities in different applications and regions for cancer biomarker in the global cancer biomarker market.
  • Strategic analysis: This includes M&A, new product development, and competitive landscape for, cancer biomarkers in the global cancer biomarker market.
  • Analysis of competitive intensity of the industry based on Porter’s Five Forces model.

This report answers following 11 key questions:

Q.1. What are some of the most promising potential, high-growth opportunities for the global cancer biomarkers market by profiling technology (omics, imaging technologies, immunoassays, cytogenetics, and bioinformatics), biomolecules type (protein biomarker, genetic biomarker, and other cancer biomarkers (cell, viral, and carbohydrate biomarkers), cancer type (breast cancer, lung cancer, colorectal cancer, prostate cancer, thyroid cancer, kidney cancer, other cancers (multiple myeloma, cervical, central nervous system cancer, gastric, liver, pancreatic, oral cavity and pharynx, stomach, and ovarian cancer), method (sample preparation, assay development, and biomarkers and testing), application (diagnostics, research, prognostics, risk assessment, and other applications (personalized medicine, surrogate endpoints, and therapeutics), and region (North America, Europe, Asia-Pacific, and Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which regions will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the drivers and challenges of the cancer biomarkers market?
Q.5. What are the business risks and threats to the cancer biomarkers market?
Q.6. What are emerging trends in this cancer biomarkers market and the reasons behind them?
Q.7. What are some changing demands of customers in the cancer biomarkers market?
Q.8. What are the new developments in the cancer biomarkers market? Which companies are leading these developments?
Q.9. Who are the major players in this cancer biomarkers market? What strategic initiatives are being implemented by key players for business growth?
Q.10. What are some of the competitive products and processes in this cancer biomarkers area and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11. What M & A activities have taken place in the last 5 years in cancer biomarkers market?
Table of Contents

1. Executive Summary

2. Market Background and Classifications
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2013 to 2024
3.1: Macroeconomic Trends and Forecast
3.2: Global Cancer Biomarker Market: Trends and Forecast
3.3: Global Cancer Biomarker Market by Profiling Technology
3.3.1: Omics
3.3.2: Imaging Technologies
3.3.3: Immunoassays
3.3.4: Cytogenetics
3.3.5: Bioinformatics
3.4: Global Cancer Biomarker Market by Biomolecules Type
3.4.1: Protein Biomarker
3.4.2: Genetic Biomarker
3.4.3: Other Cancer Biomarker
3.5: Global Cancer Biomarker Market by Cancer Type
3.5.1: Breast Cancer
3.5.2: Lung Cancer
3.5.3: Colorectal Cancer
3.5.4: Prostate Cancer
3.5.5: Thyroid Cancer
3.5.6: Kidney Cancer
3.5.7: Other Cancers
3.6: Global Cancer Biomarker Market by Method
3.6.1: Sample Preparation
3.6.2: Assay Development
3.6.3: Biomarkers and Testing
3.7: Global Cancer Biomarker Market by Application
3.7.1: Diagnostics
3.7.2: Research
3.7.3: Prognostics
3.7.4: Risk Assessment
3.7.5: Others

4. Market Trends and Forecast Analysis by Region
4.1: Global Cancer Biomarker Market by Region
4.2: North American Cancer Biomarker Market
4.2.1: Market by Profiling Technology: Omics, Imaging Technologies, Immunoassays, Cytogenetics, and
          Bioinformatics
4.2.2: Market by Biomolecules Type: Protein Biomarker, Genetic Biomarker, and Other Cancer
          Biomarker
4.2.3: Market by Cancer Type, Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer,
          Thyroid Cancer, Kidney Cancer, and Other Cancers
4.2.4: Market by Method: Sample Preparation, Assay Development, and Biomarkers and Testing
4.2.5: Market by Application: Diagnostics, Research, Prognostics, Risk Assessment, and Others
4.3: European Cancer Biomarker Market
4.3.1: Market by Profiling Technology: Omics, Imaging Technologies, Immunoassays, Cytogenetics, and
          Bioinformatics
4.3.2: Market by Biomolecules Type: Protein Biomarker, Genetic Biomarker, and Other Cancer
          Biomarker 
4.3.3: Market by Cancer Type, Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer,
          Thyroid Cancer, Kidney Cancer, and Other Cancers
4.3.4: Market by Method: Sample Preparation, Assay Development, and Biomarkers and Testing
4.3.5: Market by Application: Diagnostics, Research, Prognostics, Risk Assessment, and Others
4.4: APAC Cancer Biomarker Market
4.4.1: Market by Profiling Technology: Omics, Imaging Technologies, Immunoassays, Cytogenetics, and
          Bioinformatics
4.4.2: Market by Biomolecules Type: Protein Biomarker, Genetic Biomarker, and Other Cancer
          Biomarker
4.4.3: Market by Cancer Type, Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer,
          Thyroid Cancer, Kidney Cancer, and Other Cancers
4.4.4: Market by Method: Sample Preparation, Assay Development, and Biomarkers and Testing
4.4.5: Market by Application: Diagnostics, Research, Prognostics, Risk Assessment, and Others
4.5: ROW Cancer Biomarker Market
4.5.1: Market by Profiling Technology: Omics, Imaging Technologies, Immunoassays, Cytogenetics, and
          Bioinformatics
4.5.2: Market by Biomolecules Type: Protein Biomarker, Genetic Biomarker, and Other Cancer
          Biomarker
4.5.3: Market by Cancer Type, Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer,
          Thyroid Cancer, Kidney Cancer, and Other Cancers
4.5.4: Market by Method: Sample Preparation, Assay Development, and Biomarkers and Testing
4.5.5: Market by Application: Diagnostics, Research, Prognostics, Risk Assessment, and Others

5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Market Share Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis

6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for Global Cancer Biomarker Market by Profiling Technology
6.1.2: Growth Opportunities for Global Cancer Biomarker Market by Biomolecules Type
6.1.3: Growth Opportunities for Global Cancer Biomarker Market by Cancer Type
6.1.4: Growth Opportunities for Global Cancer Biomarker Market by Method
6.1.5: Growth Opportunities for Global Cancer Biomarker Market by Application
6.1.6: Growth Opportunities for Global Cancer Biomarker Market by Region
6.2: Emerging Trends in Global Cancer Biomarker Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of Global Cancer Biomarker Market
6.3.3: Mergers, Acquisitions and Joint Ventures in the Global Cancer Biomarker Market

7. Company Profiles of Leading Players
7.1: Thermo Fisher Scientific
7.2: Roche Diagnostics
7.3: Qiagen
7.4: Illumina
7.5: Agilent Technologies
7.6: Biomérieux
7.7: Merck & Co.
7.8: Abbott Laboratories
7.9: Becton Dickinson
7.10: Quest Diagnostics

.

Buy full report or by chapter as follows

Price by License Type:
[-] Hide Chapter Details
[Chapter Number] [Chapter Name] [Chapter Number Of Pages] [Chapter Price]
Title/Chapter Name Pages Price
Full Report: Cancer Biomarker Market: Trends, Opportunities and Competitive Analysis Full Report $ 4,850
142 figures/charts and 107 tables are provided in this 150 - page report
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
  • In-depth interviews of the major players in this market
  • Detailed secondary research from competitors’ financial statements and published data 
  • Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
  • A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
 
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process. 
 

Please sign in below to get report brochure - Cancer Biomarker Market.

At Lucintel, we respect your privacy and maintain the confidentiality of information / data provided by you
(Please enter your corporate email. * These fields are mandatory )
Have an Account / Returning Visitors?

Follow us on